Biotricity Stock Price, News & Analysis (OTCMKTS:BTCY) $1.04 +0.05 (+5.05%) (As of 12/6/2023 ET) Add Compare Share Share Today's Range$0.95▼$1.0550-Day Range$0.81▼$2.1652-Week Range$0.70▼$5.98Volume22,628 shsAverage Volume37,688 shsMarket Capitalization$8.91 millionP/E RatioN/ADividend YieldN/APrice Target$12.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings About Biotricity Stock (OTCMKTS:BTCY)Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More BTCY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BTCY Stock News HeadlinesNovember 20, 2023 | msn.comHC Wainwright & Co. Downgrades Biotricity (BTCY)November 14, 2023 | msn.comBiotricity reports Q2 resultsDecember 7, 2023 | Financial Alphas (Ad)Lithium Discovery So BIG You Can't Miss it, Even From SpaceWith the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!November 13, 2023 | benzinga.comEarnings Outlook For BiotricityNovember 2, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Releases Another Groundbreaking Product: Biotres ProOctober 31, 2023 | finance.yahoo.comBiotricity Releases Another Groundbreaking Product: Biotres ProOctober 10, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart DeviceOctober 10, 2023 | finance.yahoo.comBiotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart DeviceDecember 7, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. October 4, 2023 | finanznachrichten.deBiotricity, Inc.: CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres DeviceOctober 4, 2023 | finance.yahoo.comCORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres DeviceSeptember 29, 2023 | finance.yahoo.comBiotricity, Inc. (NASDAQ:BTCY) Could Be Riskier Than It LooksAugust 28, 2023 | usatoday.comWhy Biotricity and Waqaas Al-Siddiq are Revolutionizing Modern HealthcareAugust 20, 2023 | finance.yahoo.comBiotricity, Inc. (NASDAQ:BTCY) Q1 2024 Earnings Call TranscriptAugust 15, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business UpdatesAugust 15, 2023 | finance.yahoo.comBiotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business UpdatesAugust 14, 2023 | finance.yahoo.comBiotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15thAugust 11, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to ProfitabilityAugust 11, 2023 | finance.yahoo.comBiotricity Shows Continued Growth and Strength in its Fundamentals on its Path to ProfitabilityAugust 3, 2023 | msn.comBiotricity (BTCY) Price Target Decreased by 66.67% to 4.08July 26, 2023 | benzinga.comBiotricity Is Paving The Way For Cardiac Health In The Age Of AI TechnologyJuly 25, 2023 | finance.yahoo.comBiotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care ApplicationsJuly 23, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Regains Nasdaq Listing ComplianceJuly 21, 2023 | finance.yahoo.comBiotricity Regains Nasdaq Listing ComplianceJuly 6, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Reports Strong Start to Fiscal Year 2024July 6, 2023 | msn.comHC Wainwright & Co. Reiterates Biotricity (BTCY) Buy RecommendationJuly 6, 2023 | msn.comBiotricity (BTCY) Price Target Increased by 500.00% to 12.24See More Headlines Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2023Today12/06/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BTCY CUSIPN/A CIK1630113 Webwww.biotricity.com Phone(650) 832-1626FaxN/AEmployees55Year FoundedN/APrice Target and Rating Average Stock Price Target$12.00 High Stock Price Target$12.00 Low Stock Price Target$12.00 Potential Upside/Downside+1,106.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,660,000.00 Net Margins-163.11% Pretax Margin-163.11% Return on EquityN/A Return on Assets-252.90% Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.14 Sales & Book Value Annual Sales$11.11 million Price / Sales0.77 Cash FlowN/A Price / Cash FlowN/A Book Value($2.67) per share Price / Book-0.37Miscellaneous Outstanding Shares8,566,000Free Float6,963,000Market Cap$8.52 million OptionableNot Optionable Beta2.17 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Waqaas Al-Siddiq Ph.D. (Age 38)Founder, President, CEO & Chairman Comp: $732kMr. S. John Ayanoglou (Age 56)Chief Financial Officer Comp: $305.75kMr. Andy WongVice President of OperationsDr. George N. NikopoulosDirector of Business DevelopmentMr. Matt ZabelVice President of Sales & StrategyMr. Amir AliChief Development OfficerMore ExecutivesKey CompetitorsAinosOTCMKTS:AIMDThermoGenesisNASDAQ:THMOVivosOTCMKTS:RDGLXWELLNASDAQ:XWELAtrecaNASDAQ:BCELView All Competitors BTCY Stock Analysis - Frequently Asked Questions Should I buy or sell Biotricity stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BTCY shares. View BTCY analyst ratings or view top-rated stocks. What is Biotricity's stock price target for 2024? 1 analysts have issued 12 month price targets for Biotricity's shares. Their BTCY share price targets range from $12.00 to $12.00. On average, they anticipate the company's share price to reach $12.00 in the next year. This suggests a possible upside of 1,053.8% from the stock's current price. View analysts price targets for BTCY or view top-rated stocks among Wall Street analysts. How have BTCY shares performed in 2023? Biotricity's stock was trading at $2.6880 at the beginning of 2023. Since then, BTCY shares have decreased by 61.3% and is now trading at $1.04. View the best growth stocks for 2023 here. How were Biotricity's earnings last quarter? Biotricity, Inc. (OTCMKTS:BTCY) announced its earnings results on Tuesday, November, 14th. The company reported ($0.44) earnings per share for the quarter, missing analysts' consensus estimates of ($0.34) by $0.10. The company earned $2.89 million during the quarter, compared to analysts' expectations of $3.30 million. When did Biotricity's stock split? Biotricity's stock reverse split on the morning of Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF). How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:BTCY) was last updated on 12/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.